UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

L-Citrulline Supplementation Increases Plasma Nitric Oxide Levels and Reduces Arginase Activity in Patients With Type 2 Diabetes

Frontiers in pharmacology, 2020-12, Vol.11, p.584669-584669

2020

Volltextzugriff (PDF)

Toxicity and Cellular Uptake of Gold Nanorods in Vascular Endothelium and Smooth Muscles of Isolated Rat Blood Vessel: Importance of Surface Modification

Small (Weinheim an der Bergstrasse, Germany), 2012-04, Vol.8 (8), p.1270-1278

2012

Volltextzugriff (PDF)

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway

American Journal of Physiology: Cell Physiology, 2011-05, Vol.300 (5), p.C1181-C1192

2011

Volltextzugriff (PDF)

Vitamin D deficiency in children with bronchial asthma in southern Jordan: a cross-sectional study

Journal of international medical research, 2020-12, Vol.48 (12), p.300060520974242-300060520974242

2020

Volltextzugriff (PDF)

Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function

Cells (Basel, Switzerland), 2023-03, Vol.12 (5), p.795

2023

Volltextzugriff (PDF)

Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function

PloS one, 2015-03, Vol.10 (3), p.e0121727

2015

Volltextzugriff (PDF)

Correction: angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function

PloS one, 2015-04, Vol.10 (4), p.e0127110-e0127110

2015

Volltextzugriff (PDF)

Arginase Inhibition Suppresses Breast Cancer Cell Proliferation

The FASEB journal, 2017-04, Vol.31 (S1)

2017

Volltextzugriff (PDF)

p38 Mitogen-Activated Protein Kinase (MAPK) Increases Arginase Activity and Contributes to Endothelial Dysfunction in Corpora Cavernosa from Angiotensin-II-Treated Mice

Journal of sexual medicine, 2010-12, Vol.7 (12), p.3857-3867

2010

Volltextzugriff (PDF)

Arginase inhibition improves vascular function and restores NO production in diabetic conditions

The FASEB journal, 2018-04, Vol.32 (S1), p.569.7-569.7

2018

Volltextzugriff (PDF)

Arginase inhibition improves vascular function and restores NO production in diabetic conditions

Proceedings for Annual Meeting of The Japanese Pharmacological Society, 2018, Vol.WCP2018, p.PO1-2-13

Shatanawi, Alia

2018

Volltextzugriff (PDF)

The Effect of Ramadan Fasting on Arginase Activity in Healthy Volunteers

The FASEB journal, 2019-04, Vol.33 (S1), p.819.10-819.10

2019

Volltextzugriff (PDF)

Modulation of TREM-1, Arginase and Nitric Oxide Levels under Diabetic Conditions in Macrophages

Metabolism, clinical and experimental, 2022-03, Vol.128, p.155024, Article 155024

2022

Volltextzugriff (PDF)

Regulation of MAP kinase-mediated endothelial dysfunction in hyperglycemia via arginase I and eNOS dysregulation

Biochimica et biophysica acta. Molecular cell research, 2019-09, Vol.1866 (9), p.1398-1411

2019

Volltextzugriff (PDF)

Advanced Glycated End Products or High Glucose/Palmitate treatment modulate TREM‐1, Arginase and Nitric Oxide Levels in Macrophages

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Volltextzugriff (PDF)

Angiotensin II limits NO production by upregulating arginase through a p38 MAPK–ATF-2 pathway

European journal of pharmacology, 2015-01, Vol.746, p.106-114

2015

Volltextzugriff (PDF)

Abstract 15199: L-Citrulline Supplementation Reduces Plasma Arginase Activity in Type 2 Diabetes Patients

Circulation (New York, N.Y.), 2015-11, Vol.132 (Suppl_3 Suppl 3), p.A15199-A15199

2015

Volltextzugriff (PDF)

Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic Children

Journal of asthma and allergy, 2023-01, Vol.16, p.793-811

2023

Volltextzugriff (PDF)

Angiotensin II‐induced elevation of arginase activity and impaired vasorelaxation can be prevented by p38 MAPK inhibition

The FASEB journal, 2011-04, Vol.25, p.809.6-809.6

2011

Volltextzugriff (PDF)

High glucose limits NO production through ATF‐2 and c‐Jun transcriptional regulation of Arginase

The FASEB journal, 2012-04, Vol.26 (S1)

2012

Volltextzugriff (PDF)

Abstract 16962: Angiotensin II Limits NO Production by Upregulating Arginase through a Mitogen Activated Protein Kinase-Activating Transcription Factor-2 pathway

Circulation (New York, N.Y.), 2011-11, Vol.124 (suppl_21)

2011

Volltextzugriff (PDF)

Peroxynitrite and Hydrogen Peroxide Increase Arginase Activity through the RhoA/Rho Kinase (RAK) Pathway

The FASEB journal, 2010-04, Vol.24 (S1), p.959.4-959.4

2010

Volltextzugriff (PDF)

Angiotensin II elevates endothelial arginase activity via RhoA/MAPK pathways

The FASEB journal, 2009-04, Vol.23 (S1)

2009

Volltextzugriff (PDF)

Angiotensin II signaling mechanisms involved in the elevation of arginase activity/expression and vascular dysfunction

Shatanawi, Alia

2011

Volltextzugriff (PDF)

p38 MAPK inhibition prevents angiotensin II‐induced elevation of arginase (ARG) activity and impaired vasorelaxation

The FASEB journal, 2010-04, Vol.24 (S1), p.959.2-959.2

2010

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)
Dissertationen
(1)

Sprache

Englisch
(25)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(10)
Life Sciences & Biomedicine
(8)
Nitric Oxide
(7)
Animals
(6)
Arginase
(6)
Angiotensin Ii - Pharmacology
(4)
Arginase - Metabolism
(4)
Diabetes
(4)
Mice
(4)
P38 Mitogen-Activated Protein Kinases - Metabolism
(4)
Angiotensin Ii
(3)
Arginine
(3)
Cardiovascular Disease
(3)
Cattle
(3)
Cell Biology
(3)
Endothelial Cells - Metabolism
(3)
Endothelium, Vascular - Metabolism
(3)
Pharmacology
(3)
Pharmacology & Pharmacy
(3)
Phosphorylation
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

L-Citrulline Supplementation Increases Plasma Nitric Oxide Levels and Reduces Arginase Activity in Patients With Type 2 Diabetes

Toxicity and Cellular Uptake of Gold Nanorods in Vascular Endothelium and Smooth Muscles of Isolated Rat Blood Vessel: Importance of Surface Modification

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway

Vitamin D deficiency in children with bronchial asthma in southern Jordan: a cross-sectional study

Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function

Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function

Correction: angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function

Arginase Inhibition Suppresses Breast Cancer Cell Proliferation

p38 Mitogen-Activated Protein Kinase (MAPK) Increases Arginase Activity and Contributes to Endothelial Dysfunction in Corpora Cavernosa from Angiotensin-II-Treated Mice

Arginase inhibition improves vascular function and restores NO production in diabetic conditions

Arginase inhibition improves vascular function and restores NO production in diabetic conditions

The Effect of Ramadan Fasting on Arginase Activity in Healthy Volunteers

Modulation of TREM-1, Arginase and Nitric Oxide Levels under Diabetic Conditions in Macrophages

Regulation of MAP kinase-mediated endothelial dysfunction in hyperglycemia via arginase I and eNOS dysregulation

Advanced Glycated End Products or High Glucose/Palmitate treatment modulate TREM‐1, Arginase and Nitric Oxide Levels in Macrophages

Angiotensin II limits NO production by upregulating arginase through a p38 MAPK–ATF-2 pathway

Abstract 15199: L-Citrulline Supplementation Reduces Plasma Arginase Activity in Type 2 Diabetes Patients

Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for Jordanian Asthmatic Children

Angiotensin II‐induced elevation of arginase activity and impaired vasorelaxation can be prevented by p38 MAPK inhibition

High glucose limits NO production through ATF‐2 and c‐Jun transcriptional regulation of Arginase

Abstract 16962: Angiotensin II Limits NO Production by Upregulating Arginase through a Mitogen Activated Protein Kinase-Activating Transcription Factor-2 pathway

Peroxynitrite and Hydrogen Peroxide Increase Arginase Activity through the RhoA/Rho Kinase (RAK) Pathway

Angiotensin II elevates endothelial arginase activity via RhoA/MAPK pathways

Angiotensin II signaling mechanisms involved in the elevation of arginase activity/expression and vascular dysfunction

p38 MAPK inhibition prevents angiotensin II‐induced elevation of arginase (ARG) activity and impaired vasorelaxation

Suchergebnisse filtern